China Tianbao Group Development Company Limited (1427) AI Stock Analysis

• Market Cap: HK$178.22M
• Dividend Yield: N/A
• Average Volume (3M): 94.67K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.20
• Revenue Growth: -21.32%
• EPS Growth: -715.30%
• Country: HK
• Employees: 415
• Sector: Real Estate
• Sector Strength: 53
• Industry: Real Estate - Diversified
• EPS (TTM): -0.05
• Shares Outstanding: 877,936,000
• 10 Day Avg. Volume: 205,100
• 30 Day Avg. Volume: 94,666
• PEG Ratio: <0.01
• Price to Book (P/B): 0.20
• Price to Sales (P/S): 0.09
• P/FCF Ratio: -69.72
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 44 Neutral
• Price Target: HK$0.20 ▼(-21.20% Downside)

The overall stock score of 44 reflects significant financial challenges, including declining profitability, high leverage, and negative cash flow. Technical indicators provide some neutral signals, but valuation metrics are weak due to negative earnings and lack of dividends. These factors collectively suggest a cautious outlook for the stock.

Positive Factors

Integrated business model

The company combines property development with ongoing property-related services, creating diversified revenue streams. Structurally, this supports recurring service income and cross-selling, helping stabilize revenue mix and margins versus pure-play speculative developers over the medium term.

Exchange listing and market access

A Hong Kong Exchange listing provides durable access to institutional investors, regulatory oversight and capital markets channels. This structural access supports potential refinancing or capital raises to fund projects and manage maturities, improving strategic financing flexibility over months.

Low equity volatility

A low beta implies the equity has historically shown limited correlation with broad market swings, reflecting steadier market reactions. This can reduce market-driven refinancing pressure and appeal to lower-volatility investors, aiding financing stability and planning over the medium term.

Negative Factors

Sharp revenue decline

A greater-than-25% year-on-year revenue fall indicates materially weaker project sales and demand. Persistently shrinking top-line impairs scale economics, reduces margin recovery potential, and limits retained earnings available for reinvestment or debt repayment across the coming quarters.

No operating cash flow

Absence of operating and free cash flow is a structural liquidity concern. Without internal cash generation the company must rely on external financing to complete developments and service debt, elevating refinancing risk and constraining capital allocation and growth over the medium term.

High leverage and weak equity base

Elevated debt relative to equity and a thin equity ratio reduce financial resilience. High leverage amplifies cyclical risk in real estate, increases interest burden, limits capacity to fund new projects internally, and raises odds of covenant stress or difficult refinancing in adverse markets.

China Tianbao Group Development Company Limited Business Overview & Revenue Model

Company Description

China Tianbao Group Development Company Limited operates as a property developer and construction company in the People's Republic of China. It operates through two segments, Construction Contracting, and Property Development and Others. The Construction Contracting segment provides construction contracting services primarily as a general contractor for building construction projects; and infrastructure construction projects, such as urban roads, bridges, facilities for water supply and treatment, urban pipelines, city squares, and street lighting. It also undertakes industrial and commercial construction projects comprising steel structure, landscaping for gardens, industrial construction, and preservation of antiquities and historical buildings. This segment serves property developers and local government entities. The Property Development segment develops and sells residential properties, as well as leases and operates investment property. China Tianbao Group Development Company Limited was founded in 1998 and is headquartered in Zhuozhou, the People's Republic of China.

How the Company Makes Money

China Tianbao Group generates revenue primarily through the sale of residential and commercial properties, which constitutes its core revenue stream. The company undertakes property development projects, where it invests in land acquisition, construction, and marketing to create and sell properties at a profit. Additionally, it earns income from leasing properties that it retains within its portfolio, providing a steady stream of rental revenue. Partnerships with local governments and other developers also play a crucial role in facilitating project approvals and securing favorable development sites, thereby enhancing the company's ability to generate revenue. Market demand for real estate in urban areas further supports its sales and rental income, driven by ongoing urbanization trends and increasing population density.

China Tianbao Group Development Company Limited Financial Statement Overview

Summary

China Tianbao Group Development Company Limited exhibits declining revenue and profitability, with increasing leverage and negative cash flow trends. The company faces operational challenges and financial instability risks, reflected in its low margins, high debt, and lack of cash flow. These factors contribute to a cautious financial outlook.

Income Statement

The company experienced significant revenue decline with a 25.05% drop from 2023 to 2024. Gross profit margin decreased to 2.69%, and the company reported a negative net profit margin of -8.13% in 2024. EBIT and EBITDA margins were also negative, indicating operational challenges. The overall income statement shows a trend of decreasing profitability and increasing losses.

Balance Sheet

The debt-to-equity ratio increased to 1.59 in 2024, indicating higher leverage. The return on equity was negative at -19.38%, reflecting unprofitable operations. The equity ratio decreased to 13.68%, suggesting increased financial risk. The balance sheet reflects higher leverage and reduced equity, pointing to potential financial instability.

Cash Flow

The company showed no operating cash flow in 2024, with free cash flow remaining at zero. This indicates a lack of cash generation from core business operations. The absence of positive cash flow metrics suggests potential liquidity issues and challenges in maintaining sustainable cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.04B	2.04B	2.72B	1.92B	2.90B	3.37B
Gross Profit	59.22M	54.73M	161.91M	114.71M	243.63M	628.10M
EBITDA	-77.16M	-60.25M	131.05M	-107.06M	140.91M	541.36M
Net Income	-174.00M	-165.55M	10.99M	-347.35M	41.81M	331.67M
Balance Sheet
Total Assets	6.10B	6.25B	6.07B	6.27B	6.94B	6.46B
Cash, Cash Equivalents and Short-Term Investments	163.72M	213.72M	252.49M	300.77M	319.67M	183.92M
Total Debt	1.45B	1.36B	1.05B	904.95M	799.98M	581.41M
Total Liabilities	5.26B	5.39B	5.06B	5.27B	5.59B	5.14B
Stockholders Equity	843.88M	854.50M	1.01B	1.00B	1.35B	1.32B
Cash Flow
Free Cash Flow	136.99M	-2.50M	-30.64M	-166.04M	-155.83M	218.35M
Operating Cash Flow	175.50M	36.01M	-28.94M	-165.79M	-151.39M	232.94M
Investing Cash Flow	-58.07M	-63.11M	16.34M	47.23M	-104.07M	-34.42M
Financing Cash Flow	-269.95M	48.20M	-26.40M	95.28M	315.00M	-345.82M

China Tianbao Group Development Company Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.25
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1427, the sentiment is Negative. The current price of 0.25 is above the 20-day moving average (MA) of 0.23, above the 50-day MA of 0.23, and above the 200-day MA of 0.22, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 36.66 is Neutral, neither overbought nor oversold. The STOCH value of 45.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1427.

China Tianbao Group Development Company Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
0760	56 Neutral	HK$86.98M	-0.61	-8.38%	―	-48.96%	-185.64%
1240	52 Neutral	HK$300.70M	5.83	2.10%	―	-14.93%	―
0978	50 Neutral	HK$1.42B	-0.72	-20.96%	4.36%	-16.06%	-529.92%
2349	48 Neutral	HK$244.01M	-3.40	-12.31%	―	-0.09%	37.33%
1427	44 Neutral	HK$178.22M	-0.89	-19.00%	―	-21.32%	-715.30%
1965	37 Underperform	HK$61.20M	-0.17	-307.36%	―	-6.40%	-143.33%

China Tianbao Group Development Company Limited Corporate Events

China Tianbao Confirms Independence of Newly Appointed Non-Executive Director

China Tianbao Group Development Company Limited has issued a supplemental announcement confirming the independence of newly appointed independent non-executive director Ms. Chen Zhu, following her earlier appointment disclosed on 21 January 2026. The company stated that Ms. Chen meets all independence criteria under the Hong Kong Listing Rules, has no financial or other interests in the group or its subsidiaries, no connections with any core connected persons, and no other factors that might affect her independence, reinforcing the company’s compliance posture and governance structure while leaving all other details of the original announcement unchanged.

The most recent analyst rating on (HK:1427) stock is a Hold with a HK$0.23 price target. To see the full list of analyst forecasts on China Tianbao Group Development Company Limited stock, see the HK:1427 Stock Forecast page.

China Tianbao Group Names Veteran Healthcare Executive as Independent Non-Executive Director

China Tianbao Group Development Company Limited has appointed Ms. Chen Zhu as an independent non-executive director with effect from 21 January 2026, strengthening its board with a senior executive who brings more than three decades of hospital management and healthcare industry experience in mainland China, including leadership roles in military hospitals, the Chinese PLA General Hospital and private healthcare and medical technology enterprises. Ms. Chen will serve until October 2028 under a letter of appointment that provides for an annual director’s fee of US$20,000 and subjects her to shareholder approval and standard rotation and re-election procedures, with the company emphasizing her compliance with Hong Kong’s independence criteria and signalling a continued focus on enhancing board independence and governance oversight for stakeholders.

The most recent analyst rating on (HK:1427) stock is a Hold with a HK$0.23 price target. To see the full list of analyst forecasts on China Tianbao Group Development Company Limited stock, see the HK:1427 Stock Forecast page.

China Tianbao Group Details Board Composition and Committee Roles

China Tianbao Group Development Company Limited has reaffirmed its corporate governance structure by disclosing the current composition of its board, which includes six executive directors led by Chairman Li Baotian and CEO Shen Lifeng, and three independent non-executive directors. The company has also outlined the membership and leadership of its five key board committees—Audit, Remuneration, Nomination, Strategic Planning, and Investment Decision—clarifying the roles of each director across these bodies, with Li Baotian chairing several core committees and independent directors taking leading roles in audit and governance-related functions, signaling an emphasis on structured oversight and decision-making for the group.

The most recent analyst rating on (HK:1427) stock is a Hold with a HK$0.23 price target. To see the full list of analyst forecasts on China Tianbao Group Development Company Limited stock, see the HK:1427 Stock Forecast page.

China Tianbao Group Secures Financing for Health City Development

China Tianbao Group Development Company Limited has announced its intention to provide a corporate guarantee of up to RMB800,000,000 to China Construction Bank Corporation for its subsidiary, Huailai Tianbao Health Care Service Co., Ltd. This guarantee supports a long-term loan aimed at enhancing the subsidiary’s cash flow and facilitating the development of Tianbao Jingbei Health City. The agreement terms are considered fair and beneficial for the company and its shareholders, and the bank involved is independent of the company.

The most recent analyst rating on (HK:1427) stock is a Hold with a HK$0.24 price target. To see the full list of analyst forecasts on China Tianbao Group Development Company Limited stock, see the HK:1427 Stock Forecast page.